View
1
Download
0
Category
Preview:
Citation preview
Revised: May 2020Revised: May 2020
Nebulizers & Inhalation Medication
A Collaboration Webinar presented by the
A/B MACs & the DME MACsMay 2020
© 2020 Copyright, CGS Administrators, LLC.
© 2020 Copyright, CGS Administrators, LLC.
Once you are connected to the webinar, select “Handouts”
Select “Nebulizers March 2020.pdf” to download the presentation
TODAY’S PRESENTATION
XXX
AUDIOOnce you are connected to the audio, the PIN displays
Input the PIN on your screen into your telephone
Dial-in number and PIN are unique for each attendee
© 2020 Copyright, CGS Administrators, LLC.
Revised: May 2020
Participants CGS Administrators, LLC: http://www.cgsmedicare.com
First Coast Service Options, Inc.: http://www.fcso.com/
National Government Services: http://ngsmedicare.com/
Noridian: http://www.noridianmedicare.com/
Novitas Solutions: https://www.novitas-solutions.com/
Palmetto GBA: http://www.palmettogba.com/
WPS Government Health Administrators: https://www.wpsgha.com/
© 2020 Copyright, CGS Administrators, LLC.4
Revised: May 2020
Agenda 2019 CERT Data
Coverage Criteria
Documentation Requirements
Resources
© 2020 Copyright, CGS Administrators, LLC.5
Revised: May 2020Revised: May 2020
2019 CERT Data
© 2020 Copyright, CGS Administrators, LLC.
Revised: May 2020
CERT Errors – 2019 CERT ReportThe 2019 CERT Improper Payment Data Report was published on December 12, 2019. This report can be found on https://www.cms.govand downloaded at: https://www.cms.gov/files/document/2019-medicare-fee-service-supplemental-improper-payment-data.pdf
The overall DMEPOS CERT Error Rate was 30.7%.
Nebulizers and related inhalation medication had a 12.3% error rate with 80% of the errors from insufficient documentation.
© 2020 Copyright, CGS Administrators, LLC.7
Revised: May 2020Revised: May 2020
Coverage Criteria
© 2020 Copyright, CGS Administrators, LLC.
Revised: May 2020
Coverage Criteria OverviewThe following slides represent the foundational coverage criteria for inhalation medication and their related nebulizers/compressors.
If the inhalation medication used with the nebulizer is not covered, the nebulizer, compressor, and related accessories will be denied as not reasonable and necessary.
This policy is a “diagnosis-driven” LCD. There are specific ICD-10 codes associated with each inhalation medication. The medical condition must be outlined in the medical record and the ICD-10 code must be billed on the Medicare claim to the DME MAC.
© 2020 Copyright, CGS Administrators, LLC.9
Revised: May 2020
Coverage Criteria
© 2020 Copyright, CGS Administrators, LLC.10
SMALL VOLUME NEBULIZER A7003-A7005COMPRESSOR E0570
OBSTRUCTIVE PULMONARY
DISEASE
CYSTIC FIBROSIS CYSTIC FIBROSIS or BRONCHIECTASIS
HIV, PNEUMOCYSTOSIS, or ORGAN TRANSPLANTS
PERSISTENT PULMONARY SECRETIONS
(Group 8 Codes) (Group 9 Codes) (Group 10 Codes) (Group 4 Codes) (Group 7 Codes)
AlbuterolArformoterolBudesonideCromolyn
FormoterolIpratropiumLevalbuterol
Metaproterenol
Dornase AlphaJ7639
TobramycinJ7682
PentamidineJ2545
AcetylcysteineJ7608
Reference the “Diagnosis Codes that Support Medical Necessity” section of the Policy Article for applicable diagnoses.
Revised: May 2020
Coverage Criteria
© 2020 Copyright, CGS Administrators, LLC.11
LARGE VOLUME NEBULIZER A7007, A7017 COMPRESSOR E0565, E0572
WATER/SALINE A4217 OR A7018 or COMBINATION CODE E0585
PERSISTENT THICK AND TENACIOUS PULMONARY SECRETIONS
CYSTIC FIBROSIS | BRONCHIECTASISTRACHEOSTOMY | TRACHEOBRONCHIAL STENT
Acetylcysteine J7608
Revised: May 2020
Coverage Criteria
© 2020 Copyright, CGS Administrators, LLC.12
FILTERED NEBULIZER A7006 COMPRESSOR E0565 or E0572
HIV | PNEUMOCYSTOSIS | COMPLICATIONS OF ORGAN TRANSPLANTS
Group 1 Codes
Pentamidine J2545
Revised: May 2020
Coverage Criteria
© 2020 Copyright, CGS Administrators, LLC.13
SMALL VOLUME ULTRASONIC NEBULIZER E0574 Accessories A7013, A7014, A7016
Pulmonary Hypertension with Additional CriteriaGroup 1 Codes
Tresprostinil J7686
Revised: May 2020
Coverage Criteria
© 2020 Copyright, CGS Administrators, LLC.14
CONTROLLED-DOSE INHALATION DELIVERY SYSTEM K0730
Pulmonary Hypertension with Additional Criteria
Group 11 Codes
Iloprost Q4074
Revised: May 2020
Coverage Criteria
© 2020 Copyright, CGS Administrators, LLC.15
Pulmonary Artery Hypertension
TREPROSTINIL J7686 ILOPROST Q4074}This: Or this: But NOT this:PRIMARY Secondary to: Secondary to:PULMONARY HYPERTENSION
• connective tissue disease• thromboembolic disease• HIV infection• cirrhosis• diet drugs• congenital left-to-right shunts
• Pulmonary venous hypertension• Disorders of the respiratory system
Revised: May 2020
Coverage Criteria
If acceptable diagnosis is met, then the following must be met:
• Progression despite maximal medical and/or surgical treatment
• Mean pulmonary artery pressure is > 25 mm Hg at rest or > 30 mm Hg with exertion
• Significant symptoms present (i.e., severe dyspnea on exertion, and either fatigability, angina, or syncope)
• Treatment with oral calcium channel blocking agents tried and failed, or has been considered and ruled out
© 2020 Copyright, CGS Administrators, LLC.16
continued….
TREPROSTINIL J7686 ILOPROST Q4074}
Revised: May 2020
Coverage CriteriaA controlled dose inhalation drug delivery system (K0730) is covered:
It is reasonable and necessary to deliver iloprost (Q4074) to beneficiaries with pulmonary hypertension only. (Group 11 Codes)
Claims for code K0730 for use with other inhalation solutions will be denied as not reasonable and necessary.
If all of the criteria listed in the LCD are not met, code E0574 and the related drug (J7686) or code K0730 and the related drug Q4074 will be denied as not reasonable and necessary.
© 2020 Copyright, CGS Administrators, LLC.17
Revised: May 2020
Coverage Criteria
© 2020 Copyright, CGS Administrators, LLC.18
LARGE VOLUME ULTRASONIC NEBULIZER E0575
Please note – there is no proven clinical advantage over a pneumatic compressor and nebulizer and will be denied as not reasonable and necessary.
Revised: May 2020
Related accessories are separately payable if the compressor is covered and the accessories are medically necessary.
The following table lists the compressor/generator, which is related to the accessories described:
Coverage Criteria-Accessories
Compressor/Generator Related Accessories
E0565 A4619, A7006, A7007, A7010, A7012, A7013, A7014, A7015, A7017, A7525, E1372
E0570 A7003, A7004, A7005, A7006, A7013, A7015, A7525
E0572 A7006, A7014
E0574 A7014, A7016
E0585 A4619, A7006, A7010, A7012, A7013, A7014, A7015, A7525
K0730 A7005
© 2020 Copyright, CGS Administrators, LLC.19
Revised: May 2020
Accessories: Usual MaximumA4619 (1/month) A7003 (2/month) A7004 (2/month)
in addition to the A7003
A7005 (1/6 months) A7005 (1/3 months) only with K0730 A7006 (1/month)
A7007 (2/month) A7010 (1 unit (100 ft.)/2 months)
A7012 (2/month) A7013 (2/month) A7014 (1/3 months)
A7015 (1/month) A7016 (2/year) A7017 (1/3 yrs)
A7525 (1/month) E1372 (1/3 yrs)
© 2020 Copyright, CGS Administrators, LLC.20
Revised: May 2020
Inhalation Drugs and SolutionsAcetylcysteine(up to 74g/mo)
Albuterol (up to 465 mg/mo)
Albuterol/Ipratroprium combination(up to 186 units/mo)
Arformoterol(up to 930 mcg/mo - 62 units/mo)
Budesonide(up to 62 unit/mo)
Cromolyn sodium(up to 2480 mg/mo 248 units/mo)
Dornase alpha(up to 78 mg/mo)
Formoterol (up to 1240 mcg/mo - 62 units/mo)
Ipratroprium Bromide (up to 93mg/mo)
Levalbuterol(up to 232.5 mg/mo – 465 units/mo)
Metaproterenol(up to 2800 mg/mo - 280 units/mo)
Pentamidine(up to 300 mg/mo)
Treprostinil
(up to 31 units/mo)
Sterile saline or water (up to 56 units/mo) A4216, A4218
Distilled water, sterile water, or sterile saline in large volume nebulizer (up to 18 liters/mo)
© 2020 Copyright, CGS Administrators, LLC.21
Revised: May 2020
When albuterol, levalbuterol, or metaproterenol are prescribed as rescue/supplemental medication for beneficiaries who are taking formoterol or arformoterol, the maximum milligrams/month are:
Inhalation Drugs and Solutions
Inhalation Drugs and Solutions Maximum Milligrams/Month
Albuterol 78 mg/month
Albuterol/Ipratroprium combination 31 units/month
Levalbuterol 39 mg/month – 78 units/month
Metaproterenol 470 mg/month – 47 units/month
© 2020 Copyright, CGS Administrators, LLC.22
Revised: May 2020
Non-Coverage
© 2020 Copyright, CGS Administrators, LLC.23
Large volume pneumatic nebulizer (E0580) and water or saline used with oxygen equipment
Prefilled disposable large volume nebulizer (A7008)
Albuterol, levalbuterol and metaproterenol used at same time
Formoterol and arformoterol used at the same time
Albuterol sulfate (J7611, J7613), levalbuterol and/or ipratropiumbromide (J7644) billed with J7620
Revised: May 2020Revised: May 2020
Documentation Requirements
© 2020 Copyright, CGS Administrators, LLC.
Revised: May 2020
Medical Record Documentation
© 2020 Copyright, CGS Administrators, LLC.25
MEDICAL RECORD:
• Physician’s office notes
• Hospital notes/records
• Nursing facilities records
• Home health records
• Other health care professionals without financial motive
=
SUPPLIER-PRODUCED RECORDS
REASONABLE& NECESSARY
Revised: May 2020
Medical Record Documentation Supplier-produced records, even if signed by the ordering physician, and
attestation letters (e.g. letters of medical necessity) are deemed not to be part of a medical record for Medicare payment purposes.
Templates and forms, including CMS Certificates of Medical Necessity, are subject to corroboration with information found in the Medicare beneficiary’s medical record.
Information contained directly in the contemporaneous medical record is the source required to justify payment except as noted elsewhere for prescriptions and CMNs.
© 2020 Copyright, CGS Administrators, LLC.26
Revised: May 2020
Standard Written OrderFor dates of service on and after January 1, 2020, an SWO must be communicated to the supplier prior to claim submission and must contain all of the following:
Beneficiary's name or Medicare Beneficiary Identifier (MBI)
Order Date
General description of the item
• The description can be either a general description (e.g., wheelchair or hospital bed), a HCPCS code, a HCPCS code narrative, or a brand name/model number
• For equipment - In addition to the description of the base item, the SWO may include all concurrently ordered options, accessories or additional features that are separately billed or require an upgraded code (List each separately)
• For supplies – In addition to the description of the base item, the DMEPOS order/prescription may include all concurrently ordered supplies that are separately billed (List each separately)
Quantity to be dispensed, if applicable
Treating practitioner name or NPI
Treating practitioner's signature
© 2020 Copyright CGS Administrators, LLC.27
27
Revised: May 2020
New Order Requirements When there is a change in:
• Supplier
• Item(s) provided
• Frequency of use/dosage
• Amount prescribed
• The length of need, or when a previously established length of need expires
State law requirement
© 2020 Copyright, CGS Administrators, LLC.28
Revised: May 2020
Continued Medical Need Continued medical need can occur with the following:
• Timely medical record where the medical condition is discussed/reviewed/evaluated
– “Timely” is considered within 12 months of the date of service in question.
• Recent order or prescription
© 2020 Copyright, CGS Administrators, LLC.
Revised: May 2020Revised: May 2020
COVID-19 DME MACs
© 2020 Copyright, CGS Administrators, LLC.
Revised: May 2020
Clinical Indications for CoverageEffective for claims with dates of service on or after March 1, 2020 and for the duration of this COVID-19 PHE
Clinical indications for coverage found in respiratory, home anticoagulation management, infusion pump, and therapeutic continuous glucose monitor NCDs or LCDs will not be enforced
• Home Oxygen (NCD 240.2)
• Infusion Pumps (NCD 280.14)
• Continuous Positive Airway Pressure for Obstructive Sleep Apnea (NCD 240.4)
• Intrapulmonary Percussive Ventilator (NCD 240.5)
• Oxygen and Oxygen Equipment (L33797);
• Positive Airway Pressure Devices for the Treatment of Obstructive Sleep Apnea (L33718);
• Oral Appliances for the Treatment of Obstructive Sleep Apnea (L33611)
© 2020 Copyright, CGS Administrators, LLC.
• Respiratory Assist Devices (L33800);
• Mechanical In-exsufflation Devices (L33795)
• High Frequency Chest Wall Oscillation (L33785)
• Nebulizers (L33370)
• Glucose Monitors (L33822) – Only clinical indications for Therapeutic Continuous Glucose Monitors (CGM) are not enforced
• External Infusion Pumps (L33794);
• Infusion Pumps (NCD 280.14)
Revised: May 2020
Policy and Regulatory Revisions in Response to the COVID-19 Public Health Emergency
Treating practitioners and suppliers must still:
• Provide a standard written order (SWO) for all items.
– All items (with the exception of PMDs) can be:
» Can be provided via a verbal order
» A signature is required prior to submitting claims for payment but the order can be signed electronically.
• Ensure the items or services are reasonable and necessary.
• Document the medical necessity for all services.
– Documentation must be available upon reques.t
The DME MACs will resume enforcement of clinical indications for coverage at the conclusion of the PHE.
© 2020 Copyright, CGS Administrators, LLC.
Revised: May 2020Revised: May 2020
DME MAC Jurisdictional
Resources
© 2020 Copyright, CGS Administrators, LLC.
Revised: May 2020
Noridian Healthcare SolutionsJurisdiction A Resources
Website: https://med.noridianmedicare.com/web/jadme
IVR, Supplier Contact Center, and Telephone Reopenings: 1.866.419.9458
Noridian Medicare Portal: https://med.noridianmedicare.com/web/jadme/topics/nmp
LCDs and Policy Articles: https://med.noridianmedicare.com/web/jadme/policies/lcd/active
34 © 2020 Copyright, CGS Administrators, LLC.
Revised: May 2020
CGS Administrators, LLCJurisdiction B Resources
Website: http://www.cgsmedicare.com/jb
IVR Unit: 1.877.299.7900
myCGS Web Portal: http://www.cgsmedicare.com/jb/mycgs/index.html
Customer Service: 1.866.590.6727
Telephone Re-openings: 1.844.240.7490
LCDs and Policy Articles: http://www.cgsmedicare.com/jb/coverage/lcdinfo.html
35 © 2020 Copyright, CGS Administrators, LLC.
Revised: May 2020
CGS Administrators, LLCJurisdiction C Resources
Website: http://www.cgsmedicare.com/jc
IVR Unit: 1.866.238.9650
myCGS Web Portal: http://www.cgsmedicare.com/jc/mycgs/index.html
Customer Service: 1.866.270.4909
Telephone Re-openings: 1.866.813.7878
LCDs and Policy Articles: http://www.cgsmedicare.com/jc/coverage/lcdinfo.html
36 © 2020 Copyright, CGS Administrators, LLC.
Revised: May 2020
Noridian Healthcare SolutionsJurisdiction D Resources
Website: https://med.noridianmedicare.com/web/jddme/
IVR, Supplier Contact Center and Telephone Reopenings: 1.877.320.0390
Noridian Medicare Portal: https://med.noridianmedicare.com/web/jddme/topics/nmp
LCDs and Policy Articles: https://med.noridianmedicare.com/web/jddme/policies/lcd/active
37 © 2020 Copyright, CGS Administrators, LLC.
Revised: May 2020
Other Contractor Resources Coding - PDAC
• 1.877.735.1326
• http://www.dmepdac.com
National Supplier Clearinghouse
• 1.866.238.9652
• http://www.palmettogba.com/nsc
CEDI
• 1.866.311.9184
• http://www.ngscedi.com/ngs/portal/ngscedi
• E-mail: NGS.CEDIHelpdesk@anthem.com
© 2020 Copyright, CGS Administrators, LLC.38
Revised: May 2020Revised: May 2020
Thank you for attending!
Question and Answer
© 2020 Copyright, CGS Administrators, LLC.
Revised: May 2020
How to Participate Today
© 2020 Copyright, CGS Administrators, LLC.40
Revised: May 2020
How to Participate TodayTo Ask a Verbal Question: Raise your hand
The Green Arrow means your hand is not raised (Click to raise your hand)
The Red Arrow means your hand is raised (Click to lower your hand)
© 2020 Copyright, CGS Administrators, LLC.41
Revised: May 2020
To Ask a Question By Raising Your Hand
© 2020 Copyright, CGS Administrators, LLC.42
Revised: May 2020
DisclaimerThis presentation was current at the time it was published or uploaded onto the web. Medicare policy changes frequently so links to the source documents have been provided within the document for your reference.
This presentation was prepared as a tool to assist providers and is not intended to grant rights or impose obligations. Although every reasonable effort has been made to assure the accuracy of the information within these pages, the ultimate responsibility for the correct submission of claims and response to any remittance advice lies with the provider of services.
The Centers for Medicare & Medicaid Services (CMS) employees; agents, including CGS and its staff; and CMS’ staff make no representation, warranty, or guarantee that this compilation of Medicare information is error free and will bear no responsibility or liability for the results or consequences of the use of this guide. This publication is a general summary that explains certain aspects of the Medicare Program, but is not a legal document. The official Medicare Program provisions are contained in the relevant laws, regulations, and rulings.
This presentation may not be recorded.
© 2020 Copyright, CGS Administrators, LLC.43
Recommended